The Business Times
SUBSCRIBERS

Trump’s pharma tariffs put Singapore at ‘greatest risk’ among major exporters if no exemptions granted: economists

Without exemptions, the effective tariff rate on the Republic’s shipments could exceed 30%, compared with 4% now

Summarise
Renald Yeo

Renald Yeo

Published Fri, Sep 26, 2025 · 06:22 PM
    • Pharmaceutical firms that have broken ground on US facilities will receive exemptions.
    • Pharmaceutical firms that have broken ground on US facilities will receive exemptions. PHOTO: BT FILE

    [SINGAPORE] The Trump administration’s latest tariff salvo – this time aimed at branded or patented pharmaceutical goods – could hit Singapore particularly hard, economists warned.

    On Thursday (Sep 25), Trump announced a 100 per cent tariff on imports of branded or patented pharmaceutical goods from Oct 1, unless a company has already begun construction of a plant in the United States.

    Pharmaceutical firms that have broken ground on US facilities will receive exemptions, Trump said.

    Trump tariffsPharmaceuticalsSingapore pharmaceuticalsManufacturingSingapore manufacturingSingapore economySingapore jobs

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More